Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2026-01-08 @ 12:12 AM
Study NCT ID:
NCT05529160
Status:
COMPLETED
Last Update Posted:
2023-04-06
First Post:
2022-09-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
FERTI-LILY Safety Study
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'CASE_ONLY'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 18}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2022-07-29', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2022-09', 'completionDateStruct': {'date': '2022-09-21', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2023-04-04', 'studyFirstSubmitDate': '2022-09-01', 'studyFirstSubmitQcDate': '2022-09-01', 'lastUpdatePostDateStruct': {'date': '2023-04-06', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2022-09-06', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2022-09-20', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Safety of Device', 'timeFrame': '6 weeks', 'description': 'Occurrence of device-related adverse events.'}], 'secondaryOutcomes': [{'measure': 'Label Comprehension Assessment Protocol', 'timeFrame': '6 weeks', 'description': 'PI using questions and answers to assess comprehension and confirms subject can specify location and use of cup in vaginal model.'}, {'measure': 'Device Usability', 'timeFrame': '6 weeks', 'description': 'After use reported by subject: ease of use, user compliance, overall satisfaction, comfort, size of device.'}]}, 'oversightModule': {'isUsExport': False, 'isFdaRegulatedDrug': False, 'isUnapprovedDevice': True, 'isFdaRegulatedDevice': True}, 'conditionsModule': {'conditions': ['Natural Conception', 'Label Comprehension', 'Device Usability', 'Safety Issues']}, 'descriptionModule': {'briefSummary': 'The study is a prospective, 1-arm, open label, nonrandomized, single center study designed to evaluate label comprehension, device usability and safety of the FERTI·LILY Conception Cup. The primary safety endpoint will be an assessment of reported adverse events.\n\nSubjects will be screened -10 (±3) days prior to the baseline visit. At baseline, 15-20 subjects meeting the inclusion/exclusion criteria will be provided with a FERTI·LILY Conception Cup device and instructions for using the device. Subjects will participate in a label comprehension protocol that includes the physician confirmation that they have adequate comprehension to enroll. If not, a screen failure form is completed.\n\nSubjects will agree to try and use the device within 2 weeks of disposition therefore at baseline a two-week visit is scheduled. In the event they do not use the device within the two-week period the follow up visit can be rescheduled based on the visit window of +14 days. If it is not used within 4 weeks, the PI will have the subject return to the site to authorize another two-week period that will be captured as unscheduled follow up visit. The subject should complete the Device Experience Survey after each device use. The Device Experience Survey will be returned at this time, and adverse events will be assessed.'}, 'eligibilityModule': {'sex': 'FEMALE', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'genderBased': True, 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': "Subjects who meet study eligibility criteria will be recruited from the patient population of the Principle Investigator's clinic.", 'genderDescription': 'Subject is a female volunteer, age ≥ 18 years.', 'healthyVolunteers': True, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Subject is a female volunteer, age ≥ 18 years.\n* Subject is willing and able to provide written informed consent for study participation.\n* Subject agrees to use the FCC device as directed.\n* Subject agrees to complete all study-related assessments.\n* Subject agrees to try to use the cup within two weeks of disposition.\n* PI confirms that the subject had the adequate label comprehension to enroll in the study.\n\nExclusion Criteria:\n\n* Subject has a medical condition or other factor that, in the opinion of the investigator, would contraindicate participation in the study.\n* Subject has active bacterial vaginosis infection or vaginismus.\n* Subject has an abnormal clinically significant Pap Smear diagnosis.\n* Subject has a history of endometriosis.\n* Subject has any contraindications with the Instructions for Use.\n* Subject has an allergy to silicone.\n* Subject is pregnant or lactating.'}, 'identificationModule': {'nctId': 'NCT05529160', 'briefTitle': 'FERTI-LILY Safety Study', 'organization': {'class': 'INDUSTRY', 'fullName': 'Rosesta Medical BV'}, 'officialTitle': 'A Prospective, 1-Arm, Open Label, Non-Randomized Study of the FERTI-LILY Conception Cup Device to Assess Label Comprehension, Device Usability and Safety in Women', 'orgStudyIdInfo': {'id': 'FCC-001'}}, 'armsInterventionsModule': {'armGroups': [{'label': 'Study Population', 'description': "Up to 20 subjects will be recruited from the patient population at the Principal Investigator's clinic. Subject recruitment will end once 15 evaluable subjects have completed the study.", 'interventionNames': ['Device: FERTI LILY Conception Cup']}], 'interventions': [{'name': 'FERTI LILY Conception Cup', 'type': 'DEVICE', 'description': 'The FERTI-LILY Conception Cup is indicated for over-the-counter (OTC) home use by couples trying to conceive. The FERTI·LILY device OTC contains a cervical cap attached to a stem. The FERTI-LILY Conception Cup is intended to push semen towards the cervix as an aid in conception. It is designed to be inserted vaginally after intercourse and left in place for 20-60 minutes. The device is recommended to be used during the ovulatory phase of the menstrual cycle. It is not to be left in place for longer than six hours. The device may be re-used up to 18 times or over 6 cycles.', 'armGroupLabels': ['Study Population']}]}, 'contactsLocationsModule': {'locations': [{'zip': '33431', 'city': 'Boca Raton', 'state': 'Florida', 'country': 'United States', 'facility': 'Boca Raton Obstetrics and Gynecology', 'geoPoint': {'lat': 26.35869, 'lon': -80.0831}}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Rosesta Medical BV', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}